Koers Kun Run Biotechnology, Inc.

Aandelen

17-06-10	KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
22-04-10	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
30-03-10	KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results
13-11-09	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
30-11--1	KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
KUN RUN BIOTECHNOLOGY, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	-0,79%	-4,48%	+44,44%	+127,49%	1.206 mld.
JOHNSON & JOHNSON	+1,43%	+1,11%	+47,73%	+82,08%	665 mld.
ABBVIE INC.	+1,07%	-1,21%	+32,99%	+106,31%	515 mld.
ROCHE HOLDING AG	-0,36%	-3,25%	+47,17%	+64,58%	381 mld.
MERCK & CO., INC.	-0,14%	-1,87%	+71,05%	+40,63%	362 mld.
NOVARTIS AG	-0,78%	-0,52%	+30,57%	+57,98%	307 mld.
ASTRAZENECA PLC	-0,80%	-0,21%	+8,54%	+35,56%	289 mld.
AMGEN INC.	+0,03%	-1,20%	+45,89%	+68,76%	249 mld.
GILEAD SCIENCES, INC.	-0,41%	-2,22%	+35,24%	+105,68%	207 mld.
Gemiddelde	-0,08%	-1,54%	+40,40%	+76,56%	464,42 mld.
Gewogen gemiddelde per kap.	-0,04%	-1,96%	+42,24%	+88,38%